Ultralife Dirección

Dirección controles de criterios 1/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Michael Manna

Chief Executive Officer (CEO)

US$779.0k

Compensación total

Porcentaje del salario del CEO	48.4%
Permanencia del CEO	2yrs
Participación del CEO	0.1%
Permanencia media de la dirección	sin datos
Promedio de permanencia en la Junta Directiva	14.4yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Michael Manna en comparación con los beneficios de Ultralife?
Fecha	Compensación total	Salario	Ingresos de la empresa
Sep 30 2024	n/a	n/a	US$9m
Jun 30 2024	n/a	n/a	US$10m
Mar 31 2024	n/a	n/a	US$10m
Dec 31 2023	US$779k	US$377k	US$7m
Sep 30 2023	n/a	n/a	US$4m
Jun 30 2023	n/a	n/a	US$3m
Mar 31 2023	n/a	n/a	-US$297k
Dec 31 2022	US$317k	US$241k	-US$119k

Compensación vs. Mercado: La compensación total de Michael($USD779.04K) está por encima de la media de empresas de tamaño similar en el mercado German ($USD476.59K).

Compensación vs. Ingresos: La compensación de Michael ha aumentado más de un 20% en el último año.

CEO

Michael Manna (54 yo)

2yrs

Permanencia

US$779,043

Compensación

Mr. Michael E. Manna serves as President, Chief Executive Officer & Director at Ultralife Corporation since November 22, 2022. He was President of Battery & Energy Products at Ultralife Corporation since S...

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Michael Manna	President	2yrs	US$779.04k	0.12% € 143.3k
Bradford Whitmore	Chair of the Board of Directors	17.4yrs	US$103.00k	34.16% € 41.0m
Thomas Saeli	Independent Director	14.7yrs	US$100.42k	0.48% € 577.0k
Robert Shaw	Independent Director	14.4yrs	US$99.39k	0.39% € 470.6k
Janie Goddard	Independent Director	1.8yrs	US$82.79k	0.026% € 31.6k

14.4yrs

Permanencia media

66yo

Promedio de edad

Junta con experiencia: Los miembros de la junta directiva de ULB son experimentados ( 14.4 años antigüedad media).

Ultralife Dirección

Dirección controles de criterios 1/4

Información clave

Actualizaciones recientes de la dirección

Ultralife Corporation, Annual General Meeting, Jul 16, 2024

Independent Chairman recently bought €103k worth of stock

Independent Chairman recently bought €165k worth of stock

Independent Chairman recently bought €94k worth of stock

Independent Chairman recently bought €105k worth of stock

Independent Chairman recently bought €367k worth of stock

Recent updates

New minor risk - Share price stability

Third quarter 2024 earnings released: EPS: US$0.016 (vs US$0.082 in 3Q 2023)

Ultralife Corporation to Report Q3, 2024 Results on Nov 08, 2024

Ultralife Corporation (NasdaqGM:ULBI) signed a stock purchase agreement to acquire Electrochem Solutions, Inc. from Integer Holdings Corporation (NYSE:ITGR) for $50 million.

Second quarter 2024 earnings released: EPS: US$0.18 (vs US$0.21 in 2Q 2023)

Ultralife Corporation to Report Q2, 2024 Results on Jul 25, 2024

Ultralife Corporation, Annual General Meeting, Jul 16, 2024

New minor risk - Shareholder dilution

First quarter 2024 earnings released: EPS: US$0.18 (vs US$0.021 loss in 1Q 2023)

Ultralife Corporation to Report Q1, 2024 Results on Apr 25, 2024

New minor risk - Earnings quality

Full year 2023 earnings released: EPS: US$0.44 (vs US$0.007 loss in FY 2022)

Investor sentiment deteriorates as stock falls 16%

Full year 2023 earnings released: EPS: US$0.44 (vs US$0.007 loss in FY 2022)

Investor sentiment improves as stock rises 31%

Ultralife Corporation to Report Q4, 2023 Results on Feb 15, 2024

Independent Chairman recently bought €103k worth of stock

Independent Chairman recently bought €165k worth of stock

Independent Chairman recently bought €94k worth of stock

Third quarter 2023 earnings released: EPS: US$0.082 (vs US$0.015 loss in 3Q 2022)

Investor sentiment deteriorates as stock falls 22%

Ultralife Corporation to Report Q3, 2023 Results on Oct 26, 2023

Independent Chairman recently bought €105k worth of stock

Investor sentiment improves as stock rises 29%

Investor sentiment improves as stock rises 74%

New major risk - Share price stability

Second quarter 2023 earnings released: EPS: US$0.21 (vs US$0.032 in 2Q 2022)

Ultralife Corporation to Report Q2, 2023 Results on Jul 27, 2023

Independent Chairman recently bought €367k worth of stock

Independent Chairman recently bought €136k worth of stock

Ultralife Corporation, Annual General Meeting, Jul 19, 2023

Independent Chairman recently bought €107k worth of stock

Full year 2022 earnings released: US$0.007 loss per share (vs US$0.015 loss in FY 2021)

Independent Chairman recently bought €114k worth of stock

Full year 2022 earnings released: US$0.007 loss per share (vs US$0.015 loss in FY 2021)

Independent Chairman recently bought €264k worth of stock

Ultralife Corporation Announces Executive Changes

Insufficient new directors

Third quarter 2022 earnings released: US$0.015 loss per share (vs US$0.036 loss in 3Q 2021)

Ultralife Corporation to Report Q3, 2022 Results on Oct 27, 2022

Independent Chairman recently bought €156k worth of stock

Independent Chairman recently bought €457k worth of stock

Second quarter 2022 earnings released: EPS: US$0.032 (vs US$0.051 in 2Q 2021)

Ultralife Corporation to Report Q2, 2022 Results on Jul 28, 2022

Independent Chairman recently bought €204k worth of stock

Ultralife Corporation, Annual General Meeting, Jul 20, 2022

First quarter 2022 earnings released: US$0.01 loss per share (vs US$0.042 profit in 1Q 2021)

Insufficient new directors

Ultralife Corporation to Report Q1, 2022 Results on Apr 28, 2022

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Independent Chairman recently bought €218k worth of stock

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Ultralife Corporation (NasdaqGM:ULBI) acquired Excell Battery Company for $23.5 million.

Third quarter 2021 earnings released: US$0.036 loss per share (vs US$0.026 profit in 3Q 2020)

Independent Chairman recently bought €168k worth of stock

Second quarter 2021 earnings released: EPS US$0.051 (vs US$0.10 in 2Q 2020)

Ultralife Corporation(NasdaqGM:ULBI) dropped from Russell 2000 Defensive Index

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS US$0.042 (vs US$0.067 in 1Q 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

New 90-day high: €6.50

Full year 2020 earnings released: EPS US$0.33 (vs US$0.33 in FY 2019)

Investor sentiment deteriorated over the past week

Ultralife Corporation to Report Q4, 2020 Results on Feb 04, 2021

New 90-day high: €6.40

Market bids up stock over the past week

Market bids up stock over the past week

Third quarter earnings released